openPR Logo
Press release

Non-Small Cell Lung Cancer Market Industry Trends with Top Players AstraZeneca, F. Hoffmann-La Roche, Eli Lilly, Agennix AG, ArQule, GlaxoSmithKline

07-23-2019 01:07 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

non-small cell lung

non-small cell lung

Cancer is the disease in which cell grows abnormally and may cause a tumor. In lung cancer, the cells of lungs starts to grow in uncontrolled manner later form a tumor and can be spread into other body parts. Small cell lung cancer and non-small cell lung cancer are the two main types of lung cancer. As per the stats of Lung Cancer Alliance (leading nonprofit organization dedicated to fighting lung cancer), out of overall lung cancer, around 80 to 85% cases found are of non-small cell lung cancer type and 15-20% cases found are of small cell lung cancer type.

The different, commonly diagnosed types of non-small cell lung cancer (NSCLC) are adenocarcinoma, squamous cell carcinoma, large cell carcinoma, large cell neuroendocrine tumors. Out of all these types adenocarcinoma and squamous cell carcinoma accounts around 60% of lung cancer.

There are no exact reason defined till yet by doctors behind lung cancer but some possible reasons are smoking, air pollution, mineral and metal dust, radiation treatment of chest or breast. The lung cancer symptoms are not noticeable in its early stage because they are considered for other type of illness for example pneumonia or collapsed lung. Some symptoms of lung cancer are chest pain, harsh/raspy sound during breathing, wheezing, weight loss, continuous coughing, hoarseness or voice changes, shortness of breath, lung problems like bronchitis or pneumonia etc. might be the symptoms of lung cancer. Also, if it spreads in other parts of the body then it shows symptoms like bone pain, weakness in arm or leg, yellow skin, yellow eyes, headache and balance problems.

Request A Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/241

Some diagnosis test are performed by doctors to detect the lung cancer includes diagnostic imaging test like X-ray, MRI, Ultrasound, CT scan and PET scan, also by checking the mucous when the patient cough up for cancer cells which is called as sputum cytology or also by taking the cells of your lungs from abnormal growth area of your lung or from the fluid of lungs which is called as fine needle aspiration biopsy, bronchoscopy and Mediastinoscopy.

Non-small cell lung cancer is the leading cause of cancer related mortality in U.S. According to the data of American Cancer Society, Inc. (ACSI), NSCLC is the second most common type of cancer found in both men and women. As per the estimation of ACSI, in the year 2017 there will be around 222,500 new cases of lung cancer and 155,870 deaths will happen due to lung cancer in the united states.

Therefore, U.S. holds the largest market share of non-small cell lung cancer market followed by Europe as the large number of smokers are present in this region but in last few years the APAC region showed increased number of smokers. According to the stats of International Association for the Study of Lung Cancer (IASLC), China is the world’s largest consumer of tobacco having around 301 million smokers. While in western region the growth in number of smokers. According to the data published by World Health Organization (WHO), for the year 2012 there were around 58% of cases occurred in less developed regions.

The increasing prevalence and incident rate of lung cancer and emerging drugs will drive the market towards positive direction, also the increasing awareness about the treatment will support the growth of non-small cell lung cancer market. There are some growth restraining factors are also available that are less awareness about treatment options in emerging countries, availability of generic drugs, lack of research and development about drugs and increased expenditure on advertisements of tobacco products. According to the stats of IASLC, in 2012 tobacco industry spent $ 9.6 billion on tobacco products advertising and promotion which is 40 times greater than NIH research which spent $ 233 million on lung cancer research.

Some are the leading companies in non-small cell lung cancer are AstraZeneca Plc, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Agennix AG, ArQule Inc, GlaxoSmithKline Pharmaceuticals Limited, Daiichi Sankyo Co. Ltd., Sanofi-Aventis, and Boehringer Ingelheim GmbH. Also as per U.S. Food and Drug Administration some latest drug approvals in Market of non-small cell lung cancer by USFDA are on October 24, 2016 pembrolizumab (Merck & Co., Inc.) received approval, also FDA approved atezolizumab for the treatment of NSCLC on October 18, 2016.

Get PDF Brochure of This Business Report:
https://www.coherentmarketinsights.com/insight/request-pdf/241

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Small Cell Lung Cancer Market Industry Trends with Top Players AstraZeneca, F. Hoffmann-La Roche, Eli Lilly, Agennix AG, ArQule, GlaxoSmithKline here

News-ID: 1809320 • Views:

More Releases from Coherent Market Insights

Prebiotics for Dietary Supplements Market See Incredible Growth 2024-2031 | Clasado Biosciences, VW-Ingredients, Shandong Longli Biotechnology Co., Ltd, Prenexus Health., Ingredion, Tata Chemicals Ltd., Yakult Honsha Co., Ltd., Tate & Lyle, Roquette Frèr
Prebiotics for Dietary Supplements Market See Incredible Growth 2024-2031 | Clas …
Coherent Market Insights Published Most recent Prebiotics for Dietary Supplements Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the study considers important factors such as an analysis of the market, a definition of the market, market segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. For achieving incredible growth in business,
DNA Repair Drugs Market Expected to Expand at a Steady 2024-2031 | AstraZeneca Plc., Johnson & Johnson, GlaxoSmithKline plc., Pfizer, Inc., Clovis Oncology Inc., AbbVie Inc., Bristol - Myers Squibb, Merck KGaA, Genentech, Inc., Repare Therapeutics Inc., K
DNA Repair Drugs Market Expected to Expand at a Steady 2024-2031 | AstraZeneca P …
Coherent Market Insights Published Most recent DNA Repair Drugs Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the study considers important factors such as an analysis of the market, a definition of the market, market segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. For achieving incredible growth in business, this
Polyethylene Terephthalate (PET) Market 2024-2031: Raw Materials Requirements, Manufacturing Process, Business Plan | Alpek S.A.B de C.V., RTP Company, BASF SE
Polyethylene Terephthalate (PET) Market 2024-2031: Raw Materials Requirements, M …
This comprehensive Report of the Polyethylene Terephthalate (PET) Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. A complete and wide-ranging evaluation of the aspects that drive and restrain market growth is also provided throughout the study. This detailed exploration of the
Chlorine Market 2024-2031: Business Plan, Manufacturing Process, Machinery Requirement | BASF SE, Occidental Chemical Corporation
Chlorine Market 2024-2031: Business Plan, Manufacturing Process, Machinery Requi …
This comprehensive Report of the Chlorine Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. A complete and wide-ranging evaluation of the aspects that drive and restrain market growth is also provided throughout the study. This detailed exploration of the market size

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top